Batch 001 - Live Allocation

Next Release: Aug 2026

Vivre Labs

Institutional Longevity

Catalogue
Single-vial Blends · one injection
Clinical Details

- Peptides -

- Single-vial Blends -

- Goals -

- Clinical Reference -

- Guides -

- Integrity -

◈ V-Series Protocol

V-02

Focus - Memory & Mental Clarity

Mental clarity, sustained focus, memory support

Quick Takeaways

✓Targets BDNF / NGF neurotrophic pathways (Semax)

✓Modulates GABAergic signalling for anxiolytic effect (Selank)

✓Russian clinical-use history - honest framing of Western evidence gap

TargetsExecutive Performance · Cognitive Health

DurationOngoing protocol with 30-day optimization cycles

Cohort94 active members

Core Compounds

NAD+ IVSemaxSelank

Batch 001 Allocation

14 of 25 reserved11 open

Monthly

$350 USD/mo

Founding-Member Savings

Standard (Monthly)$350/mo

6-Month Founding Tier$315/mo

Annual savings$420

◇

Janoshik Verified

HPLC + MS purity, every batch

Independent third-party lab

⬡

COA Per Batch

Lot-level certificates published

Labeled vs actual mg disclosed

⊙

Protocol Reviewed

Clinical reasoning per stack

Phase 1 supervision onboarding

V-02 · Steel · Cognitive

Composition

Each compound, and what it does

Every component is individually sourced, third-party verified, and dispensed within physician supervision. Tap any compound for its full clinical reference.

▸

Clinical Overview

V-02 Explainer · 90 seconds

Video Coming Soon

Clinical explainer · ~90s · Authored by Vivre Labs Medical Board

◉

Patient Selection

Who This Protocol Is For

A neurotrophic protocol designed for patients managing high cognitive load, post-concussion recovery, or early signs of cognitive decline. The stack targets synaptic architecture rather than acute stimulation - measurable improvements in BDNF expression, HPA axis regulation, and mitochondrial energy metabolism.

CLINICAL INDICATION: Patients managing chronic cognitive load, post-concussion recovery, neurodegenerative risk mitigation

Cohort Outcomes · V-02

What members on Focus - Memory & Mental Clarity report.

n=61 members completing Week 12 of V-02 · Population medians, individual results vary

DHEA-S increase

+60%

Median, baseline → wk 12

hs-CRP reduction

-48%

Neuroinflammation marker

Homocysteine reduction

-32%

Methylation health

Member VL-2026-0156 (F, 46): Homocysteine 12.4 → 7.8, DHEA-S restored to age-adjusted optimum. Reports sustained focus through cognitive load without sedation rebound.

Outcomes shown reflect cohort medians from members completing 12 weeks on protocol. Individual outcomes depend on baseline biomarkers, adherence, and physician-directed adjustments. Past cohort performance does not guarantee future results.

◈

Mechanism

How V-02 Works

Neurotropic stack combining NAD+ infusion for mitochondrial NAD/NADH restoration with Semax and Selank for BDNF upregulation and HPA axis modulation. Indicated for cognitive decline risk mitigation and executive function optimization.

While stimulant nootropics target acute performance, V-02 addresses structural change. The combination of NAD+ infusion for mitochondrial energy substrate, Semax's neurotrophin amplification, and Selank's HPA axis regulation targets cognitive architecture and stress-resilience rather than acute stimulation.

◇

Formulation

What arrives each month

◇ Multi-Vial Stack

3 separate vials · Multi-route administration per physician schedule

NAD+ is delivered by IV infusion at clinical visit. Semax and Selank are intranasal. No single-vial blend exists or is appropriate across these administration routes. Available to partner practices on request - not in the Batch 001 direct catalogue.

What's in the box	Specification	Per month
NAD+ IV (500mg)IV	500mg IV bag - administered at clinic per protocol	1×
SemaxIntranasal	10mg intranasal vial	2×
SelankIntranasal	10mg intranasal vial	2×

V-02 components administered separately by route - cohort tracked across the protocol as a whole.

Vial counts shown are operational transparency - what arrives in the monthly allocation box. Administration frequency, per-administration amounts, and reconstitution method are physician-determined at consultation, not on this page.

◇

Components

Core Compounds in V-02

Metabolic Coenzyme

NAD+

High-Dose IV · 500mg

Mitochondrial NAD/NADH Restoration

View Compound →

Focus & mood

Semax

ACTH Analog · 10mg

BDNF Upregulation

View Compound →

Anxiolytic Peptide

Selank

Tuftsin Analog · 10mg

GABAergic Modulation

View Compound →

∞

Protocol Timeline

Titration Schedule

Wk 1

NAD+ 250mg IV + Semax 200mcg intranasal

Flush response assessment

Wk 2–4

NAD+ 500mg IV weekly + Semax 400mcg daily + Selank 250mcg

Therapeutic loading

Wk 5+

NAD+ 500mg bi-weekly maintenance + Semax/Selank cycling per protocol

Maintenance - HRV-guided optimization

◐

Clinical Oversight

Monitoring & Safety

Lab Monitoring

Cortisol rhythm (4-point salivary), BDNF, homocysteine, HRV baseline

Contraindications

Active seizure disorder, MAO inhibitor use, severe hepatic impairment

✚

Patient Bloodwork Guide

Bloodwork for Cognitive & Neuro Protocols

Nootropic / neuro - Semax, Selank, DSIP, Oxytocin, PT-141, Kisspeptin

These protocols target cognition, mood, stress regulation, and sleep. Their effects are mostly subjective and behavioral, so monitoring leans on functional and stress-axis markers more than a classic blood panel - the aim is to confirm benefit without disrupting your stress hormones or sleep architecture.

Incremental approach. These are low-dose, often short-course or as-needed protocols. Vivre tracks how you actually feel and function alongside a light marker panel, rather than chasing numbers - the subjective response is the primary signal here.

Stress axis & recovery

Cortisol rhythm (AM/PM)Confirms the protocol is calming the stress axis, not over-stimulating it. The key safety/efficacy marker for this group.

HRV (heart-rate variability)A non-blood measure of nervous-system balance and recovery - rises as stress regulation improves.

Brain & vascular health

HomocysteineElevated levels are linked to cognitive risk; a useful baseline to optimize.

BDNFA marker tied to neuroplasticity - context for neuro-supportive protocols (where testing is available).

Routine safety

CBC & CMPStandard blood count, liver, and kidney panels.

When the tests happen

BaselineCortisol rhythm, HRV, homocysteine, plus how you rate mood/focus/sleep.

Month 1HRV and a subjective check-in - is it helping, any over-stimulation?

Month 3Repeat cortisol rhythm and HRV to confirm a sustained, healthy direction.

Educational only - not medical advice or a dosing instruction. Your physician orders the tests, sets your dose, interprets results, and decides if a protocol is right for you. See the Informed Consent & Disclaimer for full terms.

⊟

Clinical Monitoring Reference

What Your Physician Tracks - and Why

V-02 targets cognitive and stress-axis function. The reference set below is what a Vivre physician tracks during supervised use - it describes monitoring practice, not a self-administration guide.

Dosing & Frequency

Physician-supervised protocol with review checkpoints. Dose and frequency are physician-determined by response and tolerability - never self-adjusted.

Biomarker	Why It's Monitored	Baseline	Cadence
Cortisol rhythm (4-point)	Stress-axis regulation; core mechanism target	Yes	Baseline + checkpoint
Homocysteine	Methylation and neurovascular status	Yes	Baseline + checkpoint
hs-CRP	Systemic inflammatory contribution to cognition	Yes	Baseline + checkpoint
HRV (baseline)	Autonomic balance; stress-load proxy	Yes	Periodic
Sleep/cognitive log	Subjective response tracking against markers	Yes	Ongoing

Monitoring practice shown for education. Allocation and dosing are physician-directed after consultation.

This reference describes physician monitoring practice for educational purposes. It is not a prescription, a dosing instruction, or medical advice. Treatment, dosing, and frequency are determined only by a licensed physician in consultation.

Frequently Asked

Common Questions About V-02

▣

Commonly Paired

Members on V-02 Often Add

Protocol

View protocol →

Protocol

View protocol →

Individual peptide

View compound →

Individual peptide

View compound →

READY TO PROCEED

Start with the Biological Audit

The Audit is complimentary for the Batch 001 cohort. Your physician will review your data, confirm protocol suitability, and initiate the V-02 allocation if appropriate.

$350 USD/mo

V-02 · Monthly